↓ Skip to main content

Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer Risk

Overview of attention for article published in JAMA Network Open, November 2024

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
5 X users
facebook
1 Facebook page
reddit
1 Redditor
bluesky
8 Bluesky users

Readers on

mendeley
29 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 3 10%
Professor 2 7%
Other 1 3%
Student > Doctoral Student 1 3%
Student > Ph. D. Student 1 3%
Other 1 3%
Unknown 20 69%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 8 28%
Biochemistry, Genetics and Molecular Biology 1 3%
Unknown 20 69%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 June 2026.
All research outputs
#1,621,291
of 33,192,001 outputs
Outputs from JAMA Network Open
#7,339
of 15,141 outputs
Outputs of similar age
#20,439
of 393,003 outputs
Outputs of similar age from JAMA Network Open
#271
of 592 outputs
Altmetric has tracked 33,192,001 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 15,141 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 114.3. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 393,003 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 592 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.